Pelthos Therapeutics Inc. PTHS Ratios & Valuation
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Profitability | ||||
| Gross margin | 76.3%— | —— | —— | |
| Operating margin | -193.1%— | —— | —— | |
| Net margin | -257.9%— | —— | —— | |
| Efficiency | ||||
| Asset turnover | 0.3×— | 0×— | —— | |
| Liquidity | ||||
| Current ratio | 2.1×+1.7× | 0.3×+0.3× | 0×0.0× | |
| Leverage | ||||
| Debt-to-equity | 0.1×— | —— | —— | |
| Per Share | ||||
| Book value per share | $20.68+525% | -$4.87+3.6% | -$5.05— | |
| Valuation | ||||
| Market capitalization | $98.22M+92.4% | —— | —— | |
| Price / sales | 3.6×— | —— | —— | |
| Price / book | 2.8×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pelthos Therapeutics Inc.'s profit margins?
- Pelthos Therapeutics Inc. (PTHS) runs a 79.6% gross margin and a -157.7% operating margin, with a -186.2% net margin.
- Where do Pelthos Therapeutics Inc.'s ratios come from?
- Every ratio is computed from Pelthos Therapeutics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
